TKI (Tyrosine Kinase Inhibitor)

Search documents
Exelixis (NasdaqGS:EXEL) FY Conference Transcript
2025-09-10 13:02
Exelixis (NasdaqGS:EXEL) FY Conference September 10, 2025 08:00 AM ET Company ParticipantsChristopher Senner - EVP & CFOAndrew Peters - SVP - StrategyConference Call ParticipantsRobert Burns - MD & Senior Healthcare AnalystRobert BurnsWelcome to our first fireside chat of the morning. I'm Robert Burns, Managing Director and Senior Biotech Analyst at HC Wainwright, and I'm joined today by Chris Senner, the Chief Financial Officer of Exelixis, as well as Andrew Peters, Senior Vice President of Strategy at Exe ...